These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 582817)

  • 21. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
    Yin X; Latif R; Bahn R; Tomer Y; Davies TF
    Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No association between a thyrotropin receptor gene polymorphism and Graves' disease in the female population.
    Kotsa KD; Watson PF; Weetman AP
    Thyroid; 1997 Feb; 7(1):31-3. PubMed ID: 9086566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor necrosis factor beta gene polymorphisms in Graves' disease.
    Badenhoop K; Schwarz G; Schleusener H; Weetman AP; Recks S; Peters H; Bottazzo GF; Usadel KH
    J Clin Endocrinol Metab; 1992 Feb; 74(2):287-91. PubMed ID: 1346144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D-binding protein (DBP) gene polymorphism is associated with Graves' disease and the vitamin D status in a Polish population study.
    Kurylowicz A; Ramos-Lopez E; Bednarczuk T; Badenhoop K
    Exp Clin Endocrinol Diabetes; 2006 Jun; 114(6):329-35. PubMed ID: 16868893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C3 polymorphism in Kotas and Badagas of Nilgiri Hills, south India.
    Raj BK; Shankar V; Damodaran C; Sekharan PC
    Gene Geogr; 1988 Apr; 2(1):23-6. PubMed ID: 3154770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of NFKB1 -94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease.
    Kurylowicz A; Hiromatsu Y; Jurecka-Lubieniecka B; Kula D; Kowalska M; Ichimura M; Koga H; Kaku H; Bar-Andziak E; Nauman J; Jarzab B; Ploski R; Bednarczuk T
    Genes Immun; 2007 Oct; 8(7):532-8. PubMed ID: 17690684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphism of C3 component of complement in the Polish population. II. Rare phenotypes in C3 system.
    Mańczak M
    Arch Immunol Ther Exp (Warsz); 1985; 33(3):443-52. PubMed ID: 4062509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microsatellite genotyping of chromosome 14q13.2-14q13 in the vicinity of proteasomal gene PSMA6 and association with Graves' disease in the Latvian population.
    Sjakste T; Eglite J; Sochnevs A; Marga M; Pirags V; Collan Y; Sjakste N
    Immunogenetics; 2004 Jul; 56(4):238-43. PubMed ID: 15205934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
    Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
    Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multivariate analysis of HLA loci in conjunction with a thyrotropin receptor codon 52 polymorphism in conferring risk of Graves' disease.
    Cuddihy RM; Schaid DS; Bahn RS
    Thyroid; 1996 Aug; 6(4):261-5. PubMed ID: 8875744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of the interleukin (IL)-16 gene polymorphisms with Graves' disease.
    Gu XJ; Cui B; Zhao ZF; Chen HY; Li XY; Wang S; Ning G; Zhao YJ
    Clin Immunol; 2008 Jun; 127(3):298-302. PubMed ID: 18394967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-gamma gene microsatellite polymorphisms in patients with Graves' disease.
    Siegmund T; Usadel KH; Donner H; Braun J; Walfish PG; Badenhoop K
    Thyroid; 1998 Nov; 8(11):1013-7. PubMed ID: 9848715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C3 alleles in diseases associated with C3 activation.
    Welch TR; Berry A
    Dis Markers; 1987 Jun; 5(2):81-7. PubMed ID: 3502986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.
    Zhang Q; Yang YM; Lv XY
    J Zhejiang Univ Sci B; 2006 Nov; 7(11):887-91. PubMed ID: 17048303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C3 variants in Japanese.
    Nishimukai H; Kitamura H; Sano Y; Tamaki Y
    Hum Hered; 1985; 35(2):69-72. PubMed ID: 3988301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population.
    Ichimura M; Kaku H; Fukutani T; Koga H; Mukai T; Miyake I; Yamada K; Koda Y; Hiromatsu Y
    Thyroid; 2008 Jun; 18(6):625-30. PubMed ID: 18578611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphism of C3 component of complement in the Polish population. I. Population and family studies.
    Mańczak M
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):421-30. PubMed ID: 6534316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Polymorphism of the 52 triplet gene (nucleotide 253) of the TSH receptor in Basedow-Graves patients and in healthy controls].
    Kaczur V; Szalai C; Falus A; Nagy Z; Krajczár G; Balázs C
    Orv Hetil; 1997 Jun; 138(25):1625-8. PubMed ID: 9265143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic polymorphisms associated with cigarette smoking and the risk of Graves' disease.
    Bufalo NE; Santos RB; Cury AN; Andrade RA; Morari J; Morari EC; Leite JL; Monte O; Romaldini JH; Ward LS
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):982-7. PubMed ID: 17980001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.